These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8318354)

  • 1. Neuropeptides as growth and differentiation factors in general and VIP in particular.
    Gozes I; Brenneman DE
    J Mol Neurosci; 1993; 4(1):1-9. PubMed ID: 8318354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment.
    Muller JM; Lelievre V; Becq-Giraudon L; Meunier AC
    Mol Neurobiol; 1995; 10(2-3):115-34. PubMed ID: 7576303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide growth factors and cancer.
    Woll PJ
    Br J Cancer; 1991 Mar; 63(3):469-75. PubMed ID: 2003992
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptides synthesised in the anterior pituitary: possible paracrine role.
    O'Halloran DJ; Jones PM; Bloom SR
    Mol Cell Endocrinol; 1991 Jan; 75(1):C7-12. PubMed ID: 1710997
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
    Juarranz MG; Bodega G; Prieto JC; Guijarro LG
    Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a functional significance of peptides and biogenic amines produced by the anterior pituitary.
    Houben H; Tilemans D; Denef C
    J Endocrinol Invest; 1990 Nov; 13(10):855-63. PubMed ID: 1965725
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression.
    Delgado M; Leceta J; Gomariz RP; Ganea D
    J Immunol; 1999 Oct; 163(7):3629-35. PubMed ID: 10490956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression.
    Delgado M; Sun W; Leceta J; Ganea D
    J Immunol; 1999 Oct; 163(8):4213-23. PubMed ID: 10510358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple receptors for PACAP and VIP.
    Harmar T; Lutz E
    Trends Pharmacol Sci; 1994 Apr; 15(4):97-9. PubMed ID: 7912462
    [No Abstract]   [Full Text] [Related]  

  • 10. STAT proteins participate in the regulation of the vasoactive intestinal peptide gene by the ciliary neurotrophic factor family of cytokines.
    Symes A; Lewis S; Corpus L; Rajan P; Hyman SE; Fink JS
    Mol Endocrinol; 1994 Dec; 8(12):1750-63. PubMed ID: 7708062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse.
    Gressens P; Hill JM; Paindaveine B; Gozes I; Fridkin M; Brenneman DE
    J Clin Invest; 1994 Nov; 94(5):2020-7. PubMed ID: 7962548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide synergizes with TNF-alpha in inducing human dendritic cell maturation.
    Delneste Y; Herbault N; Galea B; Magistrelli G; Bazin I; Bonnefoy JY; Jeannin P
    J Immunol; 1999 Sep; 163(6):3071-5. PubMed ID: 10477571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vasoactive intestinal peptide and galanin on survival of cultured porcine myenteric neurons.
    Arciszewski MB; Ekblad E
    Regul Pept; 2005 Feb; 125(1-3):185-92. PubMed ID: 15582731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal factors modulating immunity.
    Stanisz AM
    Neuroimmunomodulation; 1994; 1(4):217-30. PubMed ID: 7489336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4(+) T cells.
    Delgado M; Reduta A; Sharma V; Ganea D
    J Leukoc Biol; 2004 Jun; 75(6):1122-30. PubMed ID: 15020654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS as a neuropeptide disorder: peptide T, VIP, and the HIV receptor.
    Pert CB; Ruff MR; Hill JM
    Psychopharmacol Bull; 1988; 24(3):315-9. PubMed ID: 3153485
    [No Abstract]   [Full Text] [Related]  

  • 17. Is VIP a key neuropeptide in achalasia?
    Rossiter A; Guelrud M; Rossiter G
    Gastroenterology; 1994 May; 106(5):1397-8. PubMed ID: 8174904
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropeptide release from airways of young and fully-grown rabbits.
    Larsen GL; Fratelli C; Loader J; Kang JK; Dakhama A
    Pediatr Pulmonol; 2006 Dec; 41(12):1242-9. PubMed ID: 17068826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptides and neuronal survival: neuroprotective strategy for Alzheimer's disease.
    Gozes I; Bardea A; Bechar M; Pearl O; Reshef A; Zamostiano R; Davidson A; Rubinraut S; Giladi E; Fridkin M; Brenneman DE
    Ann N Y Acad Sci; 1997 Apr; 814():161-6. PubMed ID: 9160968
    [No Abstract]   [Full Text] [Related]  

  • 20. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases.
    Ganea D; Hooper KM; Kong W
    Acta Physiol (Oxf); 2015 Feb; 213(2):442-52. PubMed ID: 25422088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.